Application of MR-guided percutaneous vertebroplasty in spinal metastasis tumor

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17010663

Enrollment

Unknown

Registered

2017-02-17

Start date

2017-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal metastasis tumor

Interventions

A:MR guided group

B:CT guided group

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. the clinical diagnosis was confirmed by pathology, and the patients had the symtoms of chest, back and lumbosacral pain; 2. vertebral metastases were confirmed by CT and MRI scan, which were osteolytic destruction and exclusion of other diseases caused pain; 3. the treatment of oral pain medication is not effective or unwilling to continue to take medicine because of medication side effects.

Exclusion criteria

Exclusion criteria: 1. Aged older than 80 or younger than 18; 2. Estimated survival time less than 3 months; 3. INR>1.3; 4. Osteoblast or mixed tumor.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale Score;QOL score;	—

Secondary

Measure	Time frame
height of the vertebra;	—

Countries

China

Contacts

Public ContactJin Guangxin

Renji Hospital, School of Medicine, Shanghai Jiaotong University

jin_guangxin@163.com+86 15026683600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026